CMA-676

· Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CMA-676, covering 2012-08-22 to 2012-08-22. Get the full timeline:

Most recent: Clinical Trial Update: CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse [Phase 2]